frustrated, page-9

from the Euro presentation:
p30
"current cash = $188mil

future cash flow:
Abbott/J&J (US$55-60mil) to Q1 2011."
plus other upfronts/milestones/royalties.

I guess they could afford a dividend,
but it's just my opinion they really want to get some of their own antibodies to market for some security.
I don't hold for exactly that reason, am watching it very closely. I used to hold in EGX days but sold after the merger. It must be frustrating for PTD holders.